全文获取类型
收费全文 | 8215篇 |
免费 | 362篇 |
国内免费 | 83篇 |
专业分类
耳鼻咽喉 | 60篇 |
儿科学 | 188篇 |
妇产科学 | 93篇 |
基础医学 | 988篇 |
口腔科学 | 128篇 |
临床医学 | 429篇 |
内科学 | 2247篇 |
皮肤病学 | 101篇 |
神经病学 | 676篇 |
特种医学 | 274篇 |
外科学 | 1585篇 |
综合类 | 21篇 |
预防医学 | 149篇 |
眼科学 | 229篇 |
药学 | 467篇 |
中国医学 | 48篇 |
肿瘤学 | 977篇 |
出版年
2023年 | 49篇 |
2022年 | 92篇 |
2021年 | 149篇 |
2020年 | 75篇 |
2019年 | 115篇 |
2018年 | 157篇 |
2017年 | 150篇 |
2016年 | 175篇 |
2015年 | 183篇 |
2014年 | 234篇 |
2013年 | 263篇 |
2012年 | 462篇 |
2011年 | 542篇 |
2010年 | 369篇 |
2009年 | 282篇 |
2008年 | 526篇 |
2007年 | 551篇 |
2006年 | 555篇 |
2005年 | 577篇 |
2004年 | 526篇 |
2003年 | 575篇 |
2002年 | 626篇 |
2001年 | 96篇 |
2000年 | 76篇 |
1999年 | 102篇 |
1998年 | 150篇 |
1997年 | 117篇 |
1996年 | 106篇 |
1995年 | 91篇 |
1994年 | 92篇 |
1993年 | 108篇 |
1992年 | 60篇 |
1991年 | 65篇 |
1990年 | 36篇 |
1989年 | 34篇 |
1988年 | 37篇 |
1987年 | 48篇 |
1986年 | 25篇 |
1985年 | 22篇 |
1984年 | 23篇 |
1983年 | 18篇 |
1982年 | 12篇 |
1981年 | 13篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1977年 | 10篇 |
1976年 | 6篇 |
1975年 | 10篇 |
1974年 | 7篇 |
1973年 | 10篇 |
排序方式: 共有8660条查询结果,搜索用时 15 毫秒
171.
Kensuke Kubota Yasunobu Abe Masahiko Inamori Harunobu Kawamura Hiroyuki Kirikoshi Noritoshi Kobayashi Satoru Saito Norio Ueno Atushi Nakajima 《Journal of hepato-biliary-pancreatic sciences》2005,12(4):286-289
Endoscopic gallbladder stenting is useful palliative therapy for acute cholecystitis in high‐risk patients. Although the success rate of endoscopic gallbladder stenting is 79%–100%, an alternative method has not been reported. We succeeded in employing a method for percutaneous gallbladder stenting (PTGS) and herein describe this new method. A patient with acute acalculous cholecystitis related to ischemic atherosclerotic vascular disease, cholangitis due to Lemmel syndrome, and severe congestive heart failure underwent PTGS through the cystic duct from the gallbladder to the duodenal papilla, because an endoscopic method failed in the treatment of Lemmel syndrome. Because we were unable to place endoscopic transpapillary gallbladder drainage, percutaneous transhepatic gallbladder drainage (PTGBD) was performed and both the cholecystitis and cholangitis ceased. PTGS was performed as an alternative to endoscopic gallbladder stenting. Access to the cystic duct and gallbladder was obtained by the PTGBD route, using a guidewire (0.035‐inch diameter) and seeking catheter (6.5 Fr) under fluoroscopic control. A 7‐Fr 12‐cm double‐pigtail biliary polyethylene stent was placed. The patient remained asymptomatic for 3 months after the PTGS until he died, of an acute recurrent myocardial infarction. This new PTGS placement is an alternative treatment for symptomatic gallbladder disease in patients with increased operative risk when the endoscopic method is unsuccessful. 相似文献
172.
Clinical utility and approach to estimate postprandial hypertriglycemia by a newly designed oral fat-loading test 总被引:2,自引:0,他引:2
Igarashi M Hirata A Yamauchi T Yamaguchi H Tsuchiya H Ohnuma H Jimbu Y Okuyama Y Shirata T Otsu N Fukuyama H Takahashi S Tominaga M Kato T 《Journal of atherosclerosis and thrombosis》2003,10(5):314-320
The objective of this study was to estimate postprandial hypertriglycemia by a newly designed oral fat-loading test. Twenty-three healthy normolipidemic volunteers were orally administered a test meal consisting of a mixture of Telmeal 2.0 and 20 g of salt-free butter after fasting for 12 h. To measure the levels of total cholesterol (T-Cho), triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), remnant-like particle-cholesterol (RLP-C), lipoprotein (a) [Lp (a)], free fatty acid, apolipoproteins (Apos), plasma glucose (PG), immunoreactive insulin (IRI), and high-sensitivity C-reactive protein (hs-CRP), venous blood samples were collected before the meal and at each hour until 9 h after fat-loading. The levels of both TG and RLP-C were drastically elevated at 2 h after fat-loading and these levels remained high until 4 h (p < 0.01). A significant correlation between TG and RLP-C was also observed at 2, 3 and 4 h, and the values of the correlation coefficients (r) were 0.837, 0.838, and 0.908, respectively. In contrast, the levels of T-Cho, HDL-C, Lp (a), Apos, PG, and hs-CRP did not change. Furthermore, there were no gastrointestinal symptoms during or after the study. These results strongly suggested that this newly designed fat-loading test was very useful for evaluating postprandial hypertriglycemia, including remnant concentrations. 相似文献
173.
174.
Igarashi M Hirata A Yamaguchi H Jimbu Y Tominaga M 《Journal of atherosclerosis and thrombosis》2008,15(1):34-40
AIM: The aim of this study was to evaluate the anti-atherogenic outcomes of pioglitazone, a thiazolidinedione derivative, in type 2 diabetic patients. METHODS: Eight patients with poor diabetic control were treated with 15 mg of pioglitazone for 4 months. Blood samples were collected monthly, and the levels of fasting plasma glucose (FPG), HbA1c, and lipids, such as triglycerides, total cholesterol, low-density lipoprotein-cholesterol, and high-density lipoprotein-cholesterol, were measured. Other parameters, including immunorecative insulin (IRI), remnant-like particle-cholesterol (RLP-C), adiponectin, plasminogen activator inhibitor type 1 (PAI-1), tumor necrosis factor (TNF)- alpha , leptin, brain natriuretic peptide (BNP), and high-sensitivity (hs)-C-reactive protein (CRP), were examined at the beginning and end of the study. In addition, clinically adverse side-effects were evaluated. RESULTS: Treatment with pioglitazone significantly decreased the levels of HbA1c, FPG, the homeostasis model assessment of insulin resistance (HOMA-IR) index, RLP-C, PAI-1, TNF- alpha , and hs-CRP, but not the level, IRI, lipids, or leptin. In contrast, adverse side-effects, including body weight gain, liver dysfunction and edema, were not observed during this study. CONCLUSION: These results strongly suggested that treatment with pioglitazone has a greater clinical benefit for the prevention of atherosclerosis, including coronary heart diseases, without any adverse side-effects. 相似文献
175.
Takagi J Otake K Takahashi M Nakao N Hirooka Y Sahashi K Nogimori T 《Internal medicine (Tokyo, Japan)》2003,42(11):1117-1121
A 49-year-old man with syringomyelia and a Type I Arnold-Chiari malformation (Chiari-I) was diagnosed with growth hormone insensitivity syndrome (GHIS). He was short in stature, had high circulating levels of GH, and low circulating levels of insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3). His GH responses to the administration of growth hormone-releasing hormone (GHRH) and L-DOPA were normal, but his levels of IGF-I and IGFBP-3 did not increase after the administration of exogenous GH. Direct genomic DNA sequencing revealed neither a mutation nor deletion in this patient's GH receptor (GHR) gene, though one polymorphism was detected, indicating that his GHR gene was normal. This is the first reported case of an association of GHIS with syringomyelia and Chiari-I malformation. 相似文献
176.
Masahiko Nakayama Hisanori Kobayashi Koji Fukushima Miwako Ishido Yuji Komada Kazutake Yoshizawa 《Hepatology International》2016,10(1):158-168
Background
Simeprevir with peginterferon and ribavirin has been used for the treatment of chronic hepatitis caused by genotype 1 hepatitis C virus (HCV). We explored the predictive factors for sustained virological response (SVR) and viral relapse using datasets from four Japanese phase 3 studies (CONCERTO).Methods
We used a multiple logistic regression model. First, an integrated dataset comprising 357 patients was analyzed. Subsequently, prior treatment-naïve and relapser (223 patients) and nonresponder (134 patients) of interferon-based treatment subsets were analyzed to identify predictors of SVR. A subset of nonresponders (106 patients) who were treated ≥24 weeks was also analyzed to identify predictors for viral relapse.Results
In the integrated dataset, prior treatment response was significantly associated with SVR. In subset analyses, interleukin-28B (IL28B) TT genotype and undetectable plasma HCV RNA level at week 4 were associated in treatment-naïve patients and relapsers [odds ratio (OR); 4.106 and 3.701, respectively]. In the nonresponders, the IL28B TT genotype population was very small, and inosine triphosphatase (ITPA) and undetectable plasma HCV RNA at week 4 were associated (OR; 2.506 and 3.333, respectively). Furthermore, ribavirin dose intensity (RBV-DI) and detectable plasma HCV RNA at week 4 were significantly associated with viral relapse (OR; 0.327 and 2.922, respectively).Conclusion
IL28B and plasma HCV RNA level at week 4 were clinically relevant predictive factors for SVR in treatment-naïve patients and relapsers. Moreover, RBV-DI and plasma HCV level at week 4 were identified as relevant predictive factors for viral relapse in nonresponders.177.
Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers
下载免费PDF全文
![点击此处可从《Asian journal of endoscopic surgery》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Daisuke Hashimoto Akira Chikamoto Kazuya Sakata Shigeki Nakagawa Hiromitsu Hayashi Masaki Ohmuraya Masahiko Hirota Naoya Yoshida Toru Beppu Hideo Baba 《Asian journal of endoscopic surgery》2015,8(1):59-62
Preoperatively evaluating the resectability of pancreatobiliary cancers is difficult. The aim of this study was to investigate the benefit of staging laparoscopy in unresectable pancreatobiliary cancers. Between 2010 and 2013, 25 patients with pancreatobiliary cancers underwent staging laparoscopy after conventional tumor staging; they were compared with 10 patients who had unresectable or metastatic tumors that were found during laparotomy. Staging laparoscopy did not show unresectable factors in 11 patients, and resections were performed in these patients. Unresectable factors were found in other 14 patients who underwent staging laparoscopy. In these patients, chemotherapy was started after median postoperative day 3 (range, 2–10 days). This period was significantly longer in patients who received unnecessary laparotomy; chemotherapy was started after median postoperative day 11 (range, 6–15 days). These results suggest that staging laparoscopy, while avoiding laparotomy with unsuccessful resection, can lead to rapid induction of chemotherapy for unresectable pancreatobiliary cancers. 相似文献
178.
Hiromi Tateno MD PhD Ryuji Sakakibara MD PhD Shunsuke Shiina BSci Hirokazu Doi PhD Fuyuki Tateno MD PhD Mitsutoshi Sato PhD Tohru Masaka PhD Masahiko Kishi MD PhD Yohei Tsuyusaki MD Yosuke Aiba MD Tsuyoshi Ogata MSc Yasuo Suzuki MD PhD 《Journal of the American Geriatrics Society》2015,63(11):2416-2418
179.
Minatoguchi S Takemura G Chen XH Wang N Uno Y Koda M Arai M Misao Y Lu C Suzuki K Goto K Komada A Takahashi T Kosai K Fujiwara T Fujiwara H 《Circulation》2004,109(21):2572-2580
180.
Genshi Egusa Fumiyo Murakami Chikako Ito Yasuko Matsumoto Seijiro Kado Midori Okamura Hiroshi Mori Kiminori Yamane Hitoshi Hara Michio Yamakido 《Atherosclerosis》1993,100(2):249-255
To investigate the association of westernized food habits and concentrations of serum lipids in the Japanese, we studied 1200 healthy Japanese living in Hiroshima prefecture and 1483 ethnic Japanese from Hiroshima prefecture living in the Hawaii Islands and Los Angeles. The nutritional assessments were made by the same dietitians. No major difference was observed in the total energy intake between the Japanese and the Japanese-Americans in both males and females. However, the intake of animal fat and simple carbohydrates (especially fructose) were markedly greater, and that of complex carbohydrates lower, in the Japanese-Americans compared with the Japanese. The mean serum cholesterol (CH), LDL-CH and serum triglyceride (TG) levels were significantly higher in the Japanese-Americans in both sexes. The mean HDL-CH concentration was similar between the two groups in males, but it was approximately 7 mg/dl higher in Japanese-American females. Using the 75 percentile values of CH and TG in the Japanese in Hiroshima, the frequency of WHO types IIa and IIb hyperlipidemia was about twice as high in the Japanese-Americans. These results suggest that westernized food habits in the Japanese include qualitative changes in animal fat, simple carbohydrate and complex carbohydrate diet rather than an increase in the total energy intake. These changes are associated with marked increases in the concentrations of serum CH and TG and increased prevalence of types IIa and IIb hyperlipidemia. 相似文献